Viloxazine

This classification denotes an adrenergic uptake inhibitor and second-generation antidepressive agent with the molecular formula C13H19NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5I5Y2789ZF, chemically known as 2-(2-ethoxyphenoxymethyl)tetrahydro-1,4-oxazine but generally known as viloxazine, which bears US NIH Compound Identifier 5666. European Medicines Agency schedules Viloxazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00049MIG. World Health Organization schedules viloxazine in its Anatomical Therapeutic Chemical (ATC) Classification. VILOXAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule viloxazine under HS 29349990 and SITC 51579. As of Q4 2014, VILOXAZINE remains the US FDA Preferred Term for this commodity. SMILES: O1C(CNCC1)COC1C(OCC)CCCC1.